134 related articles for article (PubMed ID: 17981303)
1. Drug-efficacy depends on the inhibitor type and the target position in a metabolic network--a systematic study.
Gerber S; Assmus H; Bakker B; Klipp E
J Theor Biol; 2008 Jun; 252(3):442-55. PubMed ID: 17981303
[TBL] [Abstract][Full Text] [Related]
2. Detecting drug targets with minimum side effects in metabolic networks.
Li Z; Wang RS; Zhang XS; Chen L
IET Syst Biol; 2009 Nov; 3(6):523-33. PubMed ID: 19947778
[TBL] [Abstract][Full Text] [Related]
3. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox.
Becker SA; Feist AM; Mo ML; Hannum G; Palsson BØ; Herrgard MJ
Nat Protoc; 2007; 2(3):727-38. PubMed ID: 17406635
[TBL] [Abstract][Full Text] [Related]
4. Predicting novel pathways in genome-scale metabolic networks.
Schuster S; de Figueiredo LF; Kaleta C
Biochem Soc Trans; 2010 Oct; 38(5):1202-5. PubMed ID: 20863284
[TBL] [Abstract][Full Text] [Related]
5. Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis.
Ozbayraktar FB; Ulgen KO
J Biomed Inform; 2010 Aug; 43(4):537-49. PubMed ID: 20348024
[TBL] [Abstract][Full Text] [Related]
6. A computational analysis of protein interactions in metabolic networks reveals novel enzyme pairs potentially involved in metabolic channeling.
Huthmacher C; Gille C; Holzhütter HG
J Theor Biol; 2008 Jun; 252(3):456-64. PubMed ID: 17988690
[TBL] [Abstract][Full Text] [Related]
7. The markup is the model: reasoning about systems biology models in the Semantic Web era.
Kell DB; Mendes P
J Theor Biol; 2008 Jun; 252(3):538-43. PubMed ID: 18054049
[TBL] [Abstract][Full Text] [Related]
8. Biological network design strategies: discovery through dynamic optimization.
Adiwijaya BS; Barton PI; Tidor B
Mol Biosyst; 2006 Dec; 2(12):650-9. PubMed ID: 17216046
[TBL] [Abstract][Full Text] [Related]
9. Stoichiometric analysis of self-maintaining metabolisms.
Montero F; Nuño JC; Meléndez-Hevia E; Olasagasti F; Vázquez S; Morán F
J Theor Biol; 2008 Jun; 252(3):427-32. PubMed ID: 18222485
[TBL] [Abstract][Full Text] [Related]
10. Experimental validation of metabolic pathway modeling.
Moreno-Sánchez R; Encalada R; Marín-Hernández A; Saavedra E
FEBS J; 2008 Jul; 275(13):3454-69. PubMed ID: 18510554
[TBL] [Abstract][Full Text] [Related]
11. Computational approaches to the topology, stability and dynamics of metabolic networks.
Steuer R
Phytochemistry; 2007; 68(16-18):2139-51. PubMed ID: 17574639
[TBL] [Abstract][Full Text] [Related]
12. Integration of enzyme activities into metabolic flux distributions by elementary mode analysis.
Kurata H; Zhao Q; Okuda R; Shimizu K
BMC Syst Biol; 2007 Jul; 1():31. PubMed ID: 17640350
[TBL] [Abstract][Full Text] [Related]
13. Computational design of reduced metabolic networks.
Holzhütter S; Holzhütter HG
Chembiochem; 2004 Oct; 5(10):1401-22. PubMed ID: 15457535
[TBL] [Abstract][Full Text] [Related]
14. Multiobjective flux balancing using the NISE method for metabolic network analysis.
Oh YG; Lee DY; Lee SY; Park S
Biotechnol Prog; 2009; 25(4):999-1008. PubMed ID: 19572405
[TBL] [Abstract][Full Text] [Related]
15. A genome-scale, constraint-based approach to systems biology of human metabolism.
Mo ML; Jamshidi N; Palsson BØ
Mol Biosyst; 2007 Sep; 3(9):598-603. PubMed ID: 17700859
[TBL] [Abstract][Full Text] [Related]
16. Monte Carlo sampling and principal component analysis of flux distributions yield topological and modular information on metabolic networks.
Sariyar B; Perk S; Akman U; Hortaçsu A
J Theor Biol; 2006 Sep; 242(2):389-400. PubMed ID: 16860341
[TBL] [Abstract][Full Text] [Related]
17. A novel paradigm for potential drug-targets discovery: quantifying relationships of enzymes and cascade interactions of neighboring biological processes to identify drug-targets.
Chen L; Wang Q; Zhang L; Tai J; Wang H; Li W; Li X; He W; Li X
Mol Biosyst; 2011 Apr; 7(4):1033-41. PubMed ID: 21270979
[TBL] [Abstract][Full Text] [Related]
18. On flux coupling analysis of metabolic subsystems.
Marashi SA; David L; Bockmayr A
J Theor Biol; 2012 Jun; 302():62-9. PubMed ID: 22406036
[TBL] [Abstract][Full Text] [Related]
19. QSAR of cytochrome inhibitors.
Roy K; Roy PP
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1245-66. PubMed ID: 19708826
[TBL] [Abstract][Full Text] [Related]
20. Flux balance analysis of biological systems: applications and challenges.
Raman K; Chandra N
Brief Bioinform; 2009 Jul; 10(4):435-49. PubMed ID: 19287049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
